Biopharma SPAC Jiya Acquisition priced its $100M IPO. The company intends to start trading today on the Nasdaq under the symbol “JYAC”. The company in earlier filings has said it may raise up to $25 million more at the closing of any merger under terms of a forward purchase agreement. Notice of effectiveness.
Related Posts
Americas Technology Shares & Warrants Commence Separate Trading
The SPAC is targeting TMT companies -- technology, media, and telecommunications.
ECP Environmental Growth Opportunities Files for $250M IPO
ECP will focus on businesses located in North America that concentrate on combatting climate change.
Lionheart III adds $413K to Trust for Additional Month to Complete Deal with Security Matters
Announced in July at a valuation of $360 million, the deal is expected to generate proceeds of up to approximately $116 million, assuming no redemptions by Lionheart’s stockholders.
Supernova Partners II Prices Upsized $300M IPO
Supernova II plans to partner with a technology company focused on enterprise solutions.